$4.23B
$408,000
0.0% of portfolio
4,695
Q2 2024
Reduced 0.63%
$4.01B
$534,000
0.0% of portfolio
24,795
Q3 2024
Added 16.67%
$11.5B
$461,000
0.0% of portfolio
2,319
Q3 2024
Reduced 9.02%
-
$0
0.0% of portfolio
-
Q3 2024
Added 80.3%
-
$0
0.0% of portfolio
-
Q3 2024
Added 1.85%
$1.64B
$321,000
0.0% of portfolio
11,470
Q3 2024
Added 23.48%
$14.3B
$786,000
0.0% of portfolio
30,416
Q3 2024
Added 0.85%
$4.65B
$726,000
0.0% of portfolio
14,428
Q3 2024
Reduced 2.0%
$4.94B
$345,000
0.0% of portfolio
6,370
Q3 2024
Reduced 1.73%
$11.7B
$314,000
0.0% of portfolio
3,809
Q3 2024
Added 5.81%
$7.71B
$295,000
0.0% of portfolio
2,821
Q2 2024
Reduced 0.88%
$2.41B
$357,000
0.0% of portfolio
8,925
Q3 2024
Reduced 3.15%
$11.7B
$235,000
0.0% of portfolio
2,163
Q3 2024
New
$62.8B
$360,000
0.0% of portfolio
3,996
Q3 2024
Added 0.03%
$7.15B
$746,000
0.0% of portfolio
23,394
Q2 2024
Reduced 1.53%
$15.9B
$613,000
0.0% of portfolio
10,814
Q3 2024
Added 28.04%
$8.63B
$239,000
0.0% of portfolio
717
Q3 2024
New
$1.39B
$237,000
0.0% of portfolio
31,275
Q3 2024
Reduced 3.2%
$12.2B
$330,000
0.0% of portfolio
4,707
Q3 2024
Reduced 45.62%
$0
$115,000
0.0% of portfolio
10,243
Q1 2023
Reduced 6.18%
$0
$119,000
0.0% of portfolio
13,846
Q4 2023
Reduced 5.37%
$0
$120,000
0.0% of portfolio
10,000
Q3 2022
Reduced 23.18%
$3.96B
$532,000
0.0% of portfolio
3,185
Q3 2024
Reduced 26.6%
$3.28B
$238,000
0.0% of portfolio
824
Q2 2024
Reduced 27.21%
$12.5B
$442,000
0.0% of portfolio
5,500
Q3 2024
Reduced 5.03%
$896M
$56,000
0.0% of portfolio
10,421
Q2 2023
New
$3.67B
$754,000
0.0% of portfolio
16,760
Q3 2024
Added 0.13%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 17.78%
-
$0
0.0% of portfolio
-
Q3 2024
Added 57.02%
$2.77B
$718,000
0.0% of portfolio
29,642
Q1 2024
Reduced 0.51%
$4B
$472,000
0.0% of portfolio
7,023
Q3 2024
Reduced 3.3%
$13.8B
$775,000
0.0% of portfolio
7,028
Q2 2024
Added 0.96%
$19.6B
$657,000
0.0% of portfolio
9,313
Q3 2024
Reduced 1.16%
$13.1B
$613,000
0.0% of portfolio
12,536
Q3 2024
Reduced 7.49%
$10.1B
$314,000
0.0% of portfolio
735
Q3 2024
Added 27.83%
$6.94B
$288,000
0.0% of portfolio
9,077
Q2 2024
Reduced 20.0%
$8.36B
$230,000
0.0% of portfolio
5,525
Q3 2024
Added 4.34%
$12.8B
$781,000
0.0% of portfolio
6,329
Q3 2024
Reduced 0.35%
$13.3B
$273,000
0.0% of portfolio
5,586
Q3 2024
Reduced 7.79%
$73.8B
$618,000
0.0% of portfolio
5,278
Q3 2024
Added 8.89%
Canadian Pacific Kansas City
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 2.44%
$0
$335,000
0.0% of portfolio
9,646
Q3 2024
New
$0
$230,000
0.0% of portfolio
6,719
Q3 2024
New
$0
$245,000
0.0% of portfolio
8,137
Q3 2024
New
$948M
$106,000
0.0% of portfolio
18,268
Q3 2024
Reduced 8.41%
$12.4B
$306,000
0.0% of portfolio
3,958
Q3 2024
Reduced 3.65%
$27B
$397,000
0.0% of portfolio
21,485
Q3 2024
Added 5.06%
$20.3B
$737,000
0.0% of portfolio
4,237
Q3 2024
Reduced 4.72%
$3.79B
$382,000
0.0% of portfolio
8,910
Q3 2024
Reduced 3.1%
Cellectar Biosciences Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 12.5%